Cargando…

Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1β associate with COVID-19 fatal outcome: A cross-sectional analysis

The role of the mucosal pulmonary antibody response in coronavirus disease 2019 (COVID-19) outcome remains unclear. Here, we found that in bronchoalveolar lavage (BAL) samples from 48 patients with severe COVID-19-infected with the ancestral Wuhan virus, mucosal IgG and IgA specific for S1, receptor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruiz, Maria Julia, Siracusano, Gabriel, Cottignies-Calamarte, Andréa, Tudor, Daniela, Real, Fernando, Zhu, Aiwei, Pastori, Claudia, Capron, Claude, Rosenberg, Arielle R., Temperton, Nigel, Cantoni, Diego, Liao, Hanqing, Ternette, Nicola, Moine, Pierre, Godement, Mathieu, Geri, Guillaume, Chiche, Jean-Daniel, Annane, Djillali, Cramer Bordé, Elisabeth, Lopalco, Lucia, Bomsel, Morgane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560774/ https://www.ncbi.nlm.nih.gov/pubmed/36248831 http://dx.doi.org/10.3389/fimmu.2022.842468

Ejemplares similares

Antibody Fc-chimerism and effector functions: When IgG takes advantage of IgA
por: Cottignies-Calamarte, Andréa, et al.
Publicado: (2023)

Protocol to detect infectious SARS-CoV-2 at low levels using in situ hybridization techniques
por: Cottignies-Calamarte, Andréa, et al.
Publicado: (2023)

Antibody-Dependent Cellular Phagocytosis of HIV-1-Infected Cells Is Efficiently Triggered by IgA Targeting HIV-1 Envelope Subunit gp41
por: Duchemin, Maxence, et al.
Publicado: (2020)

Infection of lung megakaryocytes and platelets by SARS-CoV-2 anticipate fatal COVID-19
por: Zhu, Aiwei, et al.
Publicado: (2022)

Pannexin-1 channel opening is critical for COVID-19 pathogenesis
por: Luu, Ross, et al.
Publicado: (2021)

COVID-19 Lung Pathogenesis in SARS-CoV-2 Autopsy Cases
por: Valdebenito, Silvana, et al.
Publicado: (2021)

HIV-Sheltering Platelets From Immunological Non-Responders Induce a Dysfunctional Glycolytic CD4(+) T-Cell Profile
por: Zhu, Aiwei, et al.
Publicado: (2022)

Editorial: Platelet and megakaryocyte dysfunctions in infectious diseases
por: Assinger, Alice, et al.
Publicado: (2023)

Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms
por: Cantoni, Diego, et al.
Publicado: (2022)

Editorial: Mucosal immunity to HIV and SARS-CoV-2 infection and vaccination
por: Bomsel, Morgane, et al.
Publicado: (2023)

Humoral Immune Responses in COVID-19 Patients: A Window on the State of the Art
por: Siracusano, Gabriel, et al.
Publicado: (2020)

Profiling Antibody Response Patterns in COVID-19: Spike S1-Reactive IgA Signature in the Evolution of SARS-CoV-2 Infection
por: Siracusano, Gabriel, et al.
Publicado: (2021)

A Nonparametric Procedure for Defining a New Humoral Immunologic Profile in a Pilot Study on HIV Infected Patients
por: Brombin, Chiara, et al.
Publicado: (2013)

Human and chicken antibodies to CCR5-ECL1 block mucosal and systemic HIV infection
por: Lopalco, Lucia, et al.
Publicado: (2006)

Vasopressor Therapy and the Brain: Dark Side of the Moon
por: Heming, Nicholas, et al.
Publicado: (2020)

IgA Targeting Human Immunodeficiency Virus-1 Envelope gp41 Triggers Antibody-Dependent Cellular Cytotoxicity Cross-Clade and Cooperates with gp41-Specific IgG to Increase Cell Lysis
por: Duchemin, Maxence, et al.
Publicado: (2018)

The Protective HIV-1 Envelope gp41 Antigen P1 Acts as a Mucosal Adjuvant Stimulating the Innate Immunity
por: Xu, Lin, et al.
Publicado: (2021)

Calcitonin gene–related peptide inhibits Langerhans cell–mediated HIV-1 transmission
por: Ganor, Yonatan, et al.
Publicado: (2013)

HIV-1 Env Does Not Enable the Development of Protective Broadly Neutralizing Antibodies in an Experimental Autoimmune Encephalomyelitis Mouse Model
por: Siracusano, Gabriel, et al.
Publicado: (2021)

Native CGRP Neuropeptide and Its Stable Analogue SAX, But Not CGRP Peptide Fragments, Inhibit Mucosal HIV-1 Transmission
por: Mariotton, Jammy, et al.
Publicado: (2021)

P11-20. HIV-1 gp41-specific mucosal IgAs from highly exposed but IgG seronegative women block HIV-1 epithelial transcytosis and neutralize CD4+ cell infection
por: Tudor, D, et al.
Publicado: (2009)

Virological and Serological Discordant Profiles in COVID-19 Pneumonia: Two Atypical Clinical Cases
por: Ranzenigo, Martina, et al.
Publicado: (2020)

The CH1α domain of mucosal gp41 IgA contributes to antibody specificity and antiviral functions in HIV-1 highly exposed Sero-Negative individuals
por: Khamassi, Marwa, et al.
Publicado: (2020)

Sepsis-associated delirium: the pro and con of C5a blockade
por: Annane, Djillali
Publicado: (2009)

Critical Care Handbook of the Massachusetts General Hospital
por: Annane, Djillali
Publicado: (2011)

Corticosteroids for severe sepsis: an evidence-based guide for physicians
por: Annane, Djillali
Publicado: (2011)

Corticosteroids for sepsis: registry versus Cochrane systematic review!
por: Annane, Djillali
Publicado: (2010)

Cortisol replacement for severe sepsis and septic shock: what should I do?
por: Annane, Djillali
Publicado: (2002)

The Role of ACTH and Corticosteroids for Sepsis and Septic Shock: An Update
por: Annane, Djillali
Publicado: (2016)

Corticosteroids for COVID-19
por: Annane, Djillali
Publicado: (2021)

The pandemic in French intensive care units—Author's response
por: Annane, Djillali
Publicado: (2021)

Population pharmacokinetics of lopinavir/ritonavir in Covid-19 patients
por: Alvarez, Jean Claude, et al.
Publicado: (2020)

Population Pharmacokinetics of Hydroxychloroquine and 3 Metabolites in COVID-19 Patients and Pharmacokinetic/Pharmacodynamic Application
por: Alvarez, Jean Claude, et al.
Publicado: (2022)

The Abrogation of Phosphorylation Plays a Relevant Role in the CCR5 Signalosome Formation with Natural Antibodies to CCR5
por: Venuti, Assunta, et al.
Publicado: (2017)

Peptide P5 (residues 628–683), comprising the entire membrane proximal region of HIV-1 gp41 and its calcium-binding site, is a potent inhibitor of HIV-1 infection
por: Yu, Huifeng, et al.
Publicado: (2008)

Immunotherapy with Cell-Based Biological Drugs to Cure HIV-1 Infection
por: Siracusano, Gabriel, et al.
Publicado: (2021)

Complement Inhibition and COVID-19: The Story so Far
por: Fodil, Sofiane, et al.
Publicado: (2021)

Glucocorticoid-Glucocorticoid Receptor Response to Severe Acute Respiratory Syndrome Coronavirus 2*
por: Annane, Djillali, et al.
Publicado: (2021)

Entry of viruses through the epithelial barrier: pathogenic trickery
por: Bomsel, Morgane, et al.
Publicado: (2003)

TRPV1 activation in human Langerhans cells and T cells inhibits mucosal HIV-1 infection via CGRP-dependent and independent mechanisms
por: Mariotton, Jammy, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jumddfi88hq04vb6ko6bnbenod